The potential pro-cognitive effects with intravenous subanesthetic ketamine in adults with treatment-resistant major depressive or bipolar disorders and suicidality-Reference-Cited by-同舟云学术

The potential pro-cognitive effects with intravenous subanesthetic ketamine in adults with treatment-resistant major depressive or bipolar disorders and suicidality

Published:2021-12 Issue: Volume:144 Page:312-319
ISSN:0022-3956
Container-title:Journal of Psychiatric Research
language:en
Short-container-title:Journal of Psychiatric Research

Author:

Zhou Yanling,Wang Chengyu,Lan Xiaofeng,Zheng Wei,Li Hanqiu,Chao Ziyuan,Wu Kai,McIntyre Roger S.,Ning Yuping

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference53 articles.

1. Cognitive functioning in the first-episode of major depressive disorder: a systematic review and meta-analysis;Ahern;Neuropsychology,2017

2. Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients;Basso;J. Psychiatr. Res.,2020

3. Clinical, functional, and biological correlates of cognitive dimensions in major depressive disorder - rationale, design, and characteristics of the cognitive function and mood study (CoFaM-Study);Baune;Front. Psychiatr.,2016

4. Antidepressant effects of ketamine in depressed patients;Berman;Biol. Psychiatr.,2000

5. Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion;Chen;J. Affect. Disord.,2018

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cognitive changes in patients with unipolar TRD treated with IV ketamine: A systematic review;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-12

2. Association between cognitive functioning, suicidal ideation and suicide attempts in major depressive disorder, bipolar disorder, schizophrenia and related disorders: A systematic review and meta-analysis;Journal of Affective Disorders;2024-11

3. The association between ketamine and esketamine and suicidality: reports to the Food And Drug Administration Adverse Event Reporting System (FAERS);Expert Opinion on Drug Safety;2024-06-21

4. Ketamine Use for Palliative Care in the Austere Environment: Is Ketamine the Path Forward for Palliative Care;American Journal of Hospice and Palliative Medicine®;2024-04-17

5. Associations of MSK1 Methylation and Executive Function With Suicidal Ideation in Adolescents With Major Depressive Disorder;The Journal of Clinical Psychiatry;2024-02-21